The company has so far treated patients who were weeks or months away from a transplant, but the device is theoretically ...

The FDA has granted a breakthrough device designation to the BiVACOR Total Artificial Heart. Made of titanium, the device uses a magnetically levitated rotor to pump blood in adult patients with ...

Hadassah doctors performed the country’s first-ever complete artificial heart transplant on a 63-year-old patient, offering ...

The U.S. FDA’s decision to grant breakthrough device designation for Bivacor Inc.’s titanium total artificial heart (TAH) ...

Titanium, the main material of this artificial heart ... of the BiVACOR TAH as a temporary solution for patients suffering from severe heart failure while awaiting a transplant. Four more patients are ...

The groundbreaking, seven-hour procedure was carried out at Hadassah Ein Kerem Medical Center by an extensive medical team, ...

BiVACOR, a clinical-stage medical device company developing the world's first titanium Total Artificial Heart (TAH), today announced that its device has received Breakthrough Device Designation from ...

The BiVACOR heart, made from titanium, was implanted as a temporary ... he lived for over 100 days before receiving a successful heart transplant. “A quarter of the people waiting for a ...

Three-dimensional printing is transforming medical care, letting the health care field shift from mass-produced solutions to ...